Company Filing History:
Years Active: 2015-2017
Title: Ruchira Dasgupta: Innovator in Therapeutic Proteins
Introduction
Ruchira Dasgupta is a notable inventor based in Auburndale, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative proteins for therapeutic applications.
Latest Patents
Ruchira holds three patents, with his latest inventions focusing on fibronectin-based scaffold domain proteins that bind interleukin 23 (IL-23). These proteins specifically target the p19 subunit of IL-23 and are designed for use in therapeutic applications to treat autoimmune diseases. The inventions also encompass cells that contain these proteins, polynucleotides encoding the proteins or their fragments, and vectors that include the polynucleotides.
Career Highlights
Ruchira is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research and development efforts in the field of therapeutic proteins. His work is pivotal in addressing autoimmune diseases through innovative protein design.
Collaborations
Ruchira collaborates with talented coworkers, including Alex Bush and Linda Engle, who contribute to his research initiatives and help drive innovation within the company.
Conclusion
Ruchira Dasgupta's work in developing fibronectin-based scaffold domain proteins represents a significant advancement in therapeutic applications for autoimmune diseases. His contributions to biotechnology are noteworthy and continue to impact the field positively.